Shanghai Medicilon, Inc. engages in the preclinical comprehensive research and development services of biomedicine. It provides drug discovery, pharmaceutical research, and preclinical research services. It offers AIDS drugs, anti-cancer drug sensitizers, genetically engineered vaccines and biomedical intermediates. The company was founded by Jin Zhang Chen and Chun Lin Chen on February 2, 2004 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company